Advertisement
PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 42.96 |
| Open | 45.64 |
| Bid | 44.18 x 100 |
| Ask | 44.43 x 100 |
| Day's Range | 43.64 - 46.55 |
| 52 Week Range | 18.15 - 46.55 |
| Volume | |
| Avg. Volume | 668,193 |
| Market Cap | 3.406B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.31 |
| Earnings Date | Nov 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 41.15 |
GuruFocus.comPTC Therapeutics Inc (PTCT) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
PTC Therapeutics Inc (PTCT) reports strong Q3 revenue and raises 2024 guidance, while navigating regulatory hurdles and competitive pressures.
ZacksPTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for PTC Therapeutics (PTCT) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.